Document Detail

Influence of Dichloroacetate (DCA) on Lactate Production and Oxygen Consumption in Neuroblastoma Cells: Is DCA a Suitable Drug for Neuroblastoma Therapy?
MedLine Citation:
PMID:  22508045     Owner:  NLM     Status:  In-Data-Review    
Many cancer cells metabolize glucose preferentially via pyruvate to lactate instead to CO(2) and H(2)O (oxidative phosphorylation) even in the presence of oxygen (Warburg effect). Dichloroacetate (DCA) is a drug which is able to shift pyruvate metabolism from lactate to acetyl-CoA (tricarboxylic acid cycle) by indirect activation of pyruvate dehydrogenase (PDH). This can subsequently lead to an increased flow of oxygen in the respiratory chain, associated with enhanced generation of reactive oxygen species (ROS) which may cause apoptosis. In order to investigate if DCA may be suitable for neuroblastoma therapy, it was investigated on three human neuroblastoma cell lines whether DCA can reduce lactate production and enhance oxygen consumption. The data show, that DCA (in the low millimolar range) is able to reduce lactate production, but there was only a slight shift to increased oxygen consumption and almost no effect on cell vitality, proliferation and apoptosis of the three cell lines investigated. Therefore, DCA at low millimolar concentrations seems to be only of minor efficacy for neuroblastoma treatment.
Marena Rebekka Niewisch; Zyrafete Kuçi; Hartwig Wolburg; Mirjam Sautter; Lea Krampen; Beate Deubzer; Rupert Handgretinger; Gernot Bruchelt
Related Documents :
2386935 - Effect of tunicamycin on sialomucin and natural killer susceptibility of rat mammary tu...
191695 - Platelet aggregating material in mouse tumor cells. removal and regeneration.
6158505 - Immunoradioautographic study of alpha-fetoprotein in hepatoma cells.
286825 - Isolation and partial characterization of an epiglycanin-like glycoprotein from a new n...
10642575 - Growth differentiation factor-9 stimulates proliferation but suppresses the follicle-st...
11284735 - Modulation of epidermal growth factor receptor phosphorylation by endogenously expresse...
Publication Detail:
Type:  Journal Article     Date:  2012-04-03
Journal Detail:
Title:  Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology     Volume:  29     ISSN:  1421-9778     ISO Abbreviation:  Cell. Physiol. Biochem.     Publication Date:  2012  
Date Detail:
Created Date:  2012-04-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9113221     Medline TA:  Cell Physiol Biochem     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  373-80     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 S. Karger AG, Basel.
Department of General Paediatrics and Oncology/Haematology, University of Tübingen, Tübingen, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  RNA Interference of PARG Could Inhibit the Metastatic Potency of Colon Carcinoma Cells via PI3-Kinas...
Next Document:  MiR-206 Regulates Neural Cells Proliferation and Apoptosis via Otx2.